Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments Massimo Breccia Commentary Open access 31 January 2022 Pages: 1101 - 1106
Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy? Mário Fontes-SousaHelena MagalhãesSara Meireles Review Open access 13 January 2022 Pages: 1107 - 1125
A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab Lucinda VillaescusaFrancisco ZaragozáCristina Zaragozá Review Open access 24 January 2022 Pages: 1126 - 1148
How to Choose the Right Inhaler Using a Patient-Centric Approach? Didier CataldoShane HanonEric Derom Review Open access 26 January 2022 Pages: 1149 - 1163
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma Alessia VillaniLuca PotestioMassimiliano Scalvenzi Review Open access 28 January 2022 Pages: 1164 - 1178
Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review Juliana M. F. SallumVinay Preet KaurM. Dominik Fischer Review Open access 30 January 2022 Pages: 1179 - 1198
Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs Charmi PatelAhong HuangKruti Joshi Original Research 07 January 2022 Pages: 1199 - 1214
Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France Montserrat RosetMayur AmonkarSmita Kothari Original Research 13 January 2022 Pages: 1215 - 1229
Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies Francesca CivoliBarbara FinckVladimir Vexler Original Research Open access 16 January 2022 Pages: 1230 - 1246
Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany H. Tilman SteinmetzMoushmi SinghJörn Kohnke Original Research Open access 16 January 2022 Pages: 1247 - 1266
Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation Orazio De LuciaAngela Flavia LuppinoRoberto Caporali Original Research 16 January 2022 Pages: 1267 - 1278
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand Kriengsak VareesangthipChaicharn DeerochanawongUnchalee Permsuwan Original Research Open access 17 January 2022 Pages: 1279 - 1292
Budget Impact Analysis of Impella CP® Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis Clément DelmasMathieu PernotGuillaume Lebreton Original Research Open access 23 January 2022 Pages: 1293 - 1309
Early Changes and Predictive Value of Serum Histone H3 Concentration in Urosepsis: A Prospective Observational Study Xiangcheng ZhanDing LiuYunfei Xu Original Research Open access 23 January 2022 Pages: 1310 - 1323
Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study Diana T. AmariTimothy R. JudayEmerson M. Wickwire Original Research 24 January 2022 Pages: 1324 - 1340
Impact of Social Determinants on the Burden of Asthma and Eczema: Results from a US Patient Survey Don A. BuksteinAdam FriedmanTonya Winders Original Research Open access 24 January 2022 Pages: 1341 - 1358
Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan Toru NakazawaKanji TakahashiFumiki Shimada Original Research Open access 20 January 2022 Pages: 1359 - 1374
Assessment of the Cost-Effectiveness of HER2-Targeted Treatment Pathways in the Neoadjuvant Treatment of High-Risk HER2-Positive Early-Stage Breast Cancer Jesse A. SussellJoshua A. RothSvenn A. Hansen Original Research 30 January 2022 Pages: 1375 - 1392
Disease Activity-Guided Stepwise Tapering but Not Discontinuation of Biologics Is a Feasible Therapeutic Strategy for Patients with Ankylosing Spondylitis: Real-World Evidence Lingying YeLing ZhouHuji Xu Original Research 02 February 2022 Pages: 1393 - 1402
Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration Aki KatoTsutomu YasukawaYuichiro Ogura Original Research 03 February 2022 Pages: 1403 - 1416
iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control Fritz H. HengererGerd U. AuffarthIna Conrad-Hengerer Original Research Open access 03 February 2022 Pages: 1417 - 1431
Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort Carol PollockGlen JamesRoberto Pecoits-Filho Brief Report Open access 03 February 2022 Pages: 1432 - 1445
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study Maggie TabbererC. Elaine JonesDavid A. Lipson Correction 21 January 2022 Pages: 1446 - 1446
